Renal Disease Clinical Trials

8 recruiting

Renal Disease Trials at a Glance

99 actively recruiting trials for renal disease are listed on ClinicalTrialsFinder across 6 cities in 47 countries. The largest study group is Not Applicable with 43 trials, with the heaviest enrollment activity in Boston, New York, and Baltimore. Lead sponsors running renal disease studies include First Affiliated Hospital of Wannan Medical College, Mario Negri Institute for Pharmacological Research, and Fresenius Medical Care Deutschland GmbH.

Browse renal disease trials by phase

Treatments under study

About Renal Disease Clinical Trials

Looking for clinical trials for Renal Disease? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Renal Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Renal Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 99 trials

Recruiting
Not Applicable

Effect of Apiban Therapy on AVF Maturation in ESRD Patients

Direct Oral Anticoagulants (DOACs)Arterio-venous Fistula, Maturation, Chronic Kidney DiseaseEndstage Renal Disease
Combined military hospital lahore190 enrolled1 locationNCT07559942
Recruiting

Kidney Precision Medicine Project

Chronic Kidney DiseasesType 1 Diabetes (T1D)Kidney Failure, Acute+12 more
Icahn School of Medicine at Mount Sinai1,000 enrolled13 locationsNCT04334707
Recruiting
Not Applicable

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

DiabetesEnd Stage Renal Disease
Sonavex, Inc.304 enrolled21 locationsNCT06190717
Recruiting

Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI)

Chronic Kidney DiseasesEnd Stage Renal Disease (ESRD)Calciphylaxis+2 more
Odense University Hospital860 enrolled1 locationNCT07511283
Recruiting
Not Applicable

Solv Multi-Pass Hemodialysis System In-Center Clinical Study

End Stage Renal Disease
Mozarc Medical US LLC46 enrolled1 locationNCT07216885
Recruiting
Not Applicable

Light Therapy in End Stage Kidney Disease

End Stage Renal Disease
University of Pennsylvania60 enrolled1 locationNCT06310161
Recruiting
Phase 1Phase 2

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

Kidney TransplantationXenotransplantationESRD (End-Stage Renal Disease)
United Therapeutics50 enrolled2 locationsNCT06878560
Recruiting
Phase 3

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

End Stage Renal Disease
Iperboreal Pharma Srl170 enrolled41 locationsNCT03994471
Recruiting
Phase 2Phase 3

Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

End Stage Renal Disease
Roberto Gedaly78 enrolled1 locationNCT03321656
Recruiting
Not Applicable

CAPABLE Transplant

Quality of LifeDisability PhysicalDepression+1 more
Johns Hopkins University43 enrolled1 locationNCT06326905
Recruiting
Not Applicable

Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients

End Stage Kidney Disease (ESRD)End Stage Renal Disease (ESRD)Peritoneal Dialysis (PD)+1 more
National University of Malaysia100 enrolled1 locationNCT07157397
Recruiting
Phase 3

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

End Stage Renal DiseaseDelayed Graft FunctionDeceased Donor Kidney Transplant
Apellis Pharmaceuticals, Inc.320 enrolled1 locationNCT07020832
Recruiting
Not Applicable

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

End Stage Renal DiseaseChronic Kidney Disease Stage 5
University of Manitoba340 enrolled5 locationsNCT05726526
Recruiting
Not Applicable

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

Chronic Kidney DiseasesArteriovenous FistulaVascular Access Complication+7 more
VenoStent600 enrolled28 locationsNCT06001827
Recruiting
Not Applicable

Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.

End Stage Renal Disease
Central Hospital, Nancy, France2,293 enrolled3 locationsNCT06257134
Recruiting

Assessment of depressive and anxiety in dialysis patients undergoing virtual reality (VR) therapy

end stage renal diseases
Wroclaw University of Health and Sport Sciences80 enrolled1 locationACTRN12626000164392
Recruiting
Not Applicable

Rheopheresis as Adjuvant Treatment of Calciphylaxis

Rare DiseasesEnd Stage Renal DiseaseMetabolic Disorder
University Hospital, Lille138 enrolled29 locationsNCT04654000
Recruiting

Cooperative Assessment of Late Effects for SCD Curative Therapies

Sickle Cell DiseaseHeart DiseasePulmonary Disease+1 more
Vanderbilt University Medical Center750 enrolled5 locationsNCT05153967
Recruiting
Phase 3

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

HyperphosphatemiaDialysisChronic Kidney Disease, Receiving Dialysis+1 more
Alebund Pharmaceuticals264 enrolled42 locationsNCT06933472
Recruiting
Not Applicable

Pivotal Study of the Velocity™ pAVF System

Chronic Kidney DiseaseEnd Stage Renal Disease (ESRD)Hemodialysis Access+1 more
Venova Medical126 enrolled10 locationsNCT07153939